0000950103-21-009114.txt : 20210621 0000950103-21-009114.hdr.sgml : 20210621 20210621204712 ACCESSION NUMBER: 0000950103-21-009114 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lambert James Vincent CENTRAL INDEX KEY: 0001627139 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36042 FILM NUMBER: 211032753 MAIL ADDRESS: STREET 1: 9315 ELGIN LANE CITY: FREDERICK STATE: MD ZIP: 21704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRECIGEN, INC. CENTRAL INDEX KEY: 0001356090 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20374 SENECA MEADOWS PARKWAY CITY: GERMANTOWN STATE: MD ZIP: 20876 BUSINESS PHONE: 301-556-9900 MAIL ADDRESS: STREET 1: 20374 SENECA MEADOWS PARKWAY CITY: GERMANTOWN STATE: MD ZIP: 20876 FORMER COMPANY: FORMER CONFORMED NAME: INTREXON CORP DATE OF NAME CHANGE: 20060313 3 1 dp152669_lambert.xml FORM 3 X0206 3 2021-06-10 0 0001356090 PRECIGEN, INC. PGEN 0001627139 Lambert James Vincent 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 0 1 0 0 Ex. Dir. Fin., PGEN Ther. Inc. Common Stock 12356 D Option to Purchase Common Stock (Right to Buy) 22.56 2027-06-16 Common Stock 10000 D Option to Purchase Common Stock (Right to Buy) 8.17 2031-04-21 Common Stock 10000 D Restricted Stock Units Common Stock 2170 D The stock options are fully vested. The stock options vest in equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025. The restricted stock units ("RSUs") vest in full on January 2, 2022. Each RSU represents a contingent right to receive one share of Precigen Common Stock. /s/ James V. Lambert, by Donald P. Lehr, as attorney-in-fact 2021-06-21 EX-24 2 dp152996_ex24.htm EXHIBIT 24

Exhibit 24

SECTION 16

POWER OF ATTORNEY

I, James V. Lambert, do hereby constitute and appoint Donald P. Lehr, my true and lawful attorneys-in-fact, either of whom acting singly is hereby authorized, for me and in my name and on my behalf as a director, officer and/or shareholder of PRECIGEN, INC. to (i) prepare, execute in my name and on my behalf, and submit to the U.S. Securities and Exchange Commission (the SEC) a Form ID, including any necessary amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling me to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC in respect thereof; and (ii) prepare, execute and file any and all forms, instruments or documents, including any necessary amendments thereto, as such attorneys or attorney deems necessary or advisable to enable me to comply with Section 16 of the Securities Exchange Act of 1934 or any rule or regulation of the SEC in respect thereof (collectively, Section 16). I do hereby ratify and confirm all acts my said attorney shall do or cause to be done by virtue hereof. I acknowledge that the foregoing attorneys-in-fact, serving in such capacity at my request, are not assuming, nor is PRECIGEN, INC. assuming, any of my responsibilities to comply with Section 16.

This power of attorney shall remain in full force and effect until it is revoked by the undersigned in a signed writing delivered to each such attorney-in-fact or the undersigned is no longer required to comply with Section 16, whichever occurs first.

WITNESS the execution hereof this 21st day of June, 2021.

/s/ James V. Lambert_________________________

James V. Lambert